Renoprotective Effects of DPP-4 Inhibitors

Volume: 10, Issue: 2, Pages: 246 - 246
Published: Feb 5, 2021
Abstract
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a ubiquitous protein with exopeptidase activity that exists in cell membrane-bound and soluble forms. It has been shown that an increased renal DPP-4...
Paper Details
Title
Renoprotective Effects of DPP-4 Inhibitors
Published Date
Feb 5, 2021
Volume
10
Issue
2
Pages
246 - 246
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.